NUFORMIX PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.19 GBX | -5.00% |
|
-7.32% | -41.54% |
| Mar. 01 | Nuformix announces subscription to raise GBP150,000 | AN |
| Jan. 15 | Nuformix plc Reports Earnings Results for the Eighteen Months Ended September 30, 2023 | CI |
Valuation
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 13.36 | 30.52 | 16.66 | 7.839 | 2.554 | 1.935 |
| Enterprise Value (EV) 1 | 13.05 | 30.53 | 16.2 | 6.169 | 2.089 | 1.733 |
| P/E ratio | -5.89 x | -18 x | -21.5 x | -6.14 x | -1.94 x | -3.27 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 891 x | 50 x | 31.1 x | 40.1 x | 51.1 x | - |
| EV / Revenue | 870 x | 50 x | 30.3 x | 31.5 x | 41.8 x | - |
| EV / EBITDA | -15.3 x | -39 x | -18.9 x | -4.74 x | -1.69 x | -2.98 x |
| EV / FCF | 54.2 x | 38.7 x | -19.3 x | -13.4 x | -2.03 x | - |
| FCF Yield | 1.84% | 2.58% | -5.19% | -7.48% | -49.3% | - |
| Price to Book | 2.97 x | 7.85 x | 3.51 x | 1.38 x | 0.47 x | 0.46 x |
| Nbr of stocks (in thousands) | 460,750 | 469,467 | 490,145 | 591,609 | 709,309 | 744,309 |
| Reference price 2 | 0.0290 | 0.0650 | 0.0340 | 0.0132 | 0.003600 | 0.002600 |
| Announcement Date | 8/16/18 | 8/1/19 | 7/28/20 | 7/23/21 | 7/31/22 | 1/15/24 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.015 | 0.61 | 0.535 | 0.1956 | 0.05 | - |
| EBITDA 1 | -0.8519 | -0.7818 | -0.8571 | -1.3 | -1.233 | -0.5819 |
| EBIT 1 | -0.8994 | -0.8346 | -0.914 | -1.373 | -1.27 | -0.6186 |
| Operating Margin | -5,995.76% | -136.82% | -170.85% | -701.96% | -2,540.54% | - |
| Earnings before Tax (EBT) 1 | -1.965 | -1.843 | -0.9299 | -1.376 | -1.27 | -0.6186 |
| Net income 1 | -1.838 | -1.661 | -0.7564 | -1.253 | -1.109 | -0.573 |
| Net margin | -12,255.09% | -272.33% | -141.38% | -641.01% | -2,217.99% | - |
| EPS 2 | -0.004921 | -0.003605 | -0.001585 | -0.002158 | -0.001853 | -0.000796 |
| Free Cash Flow 1 | 0.2406 | 0.7882 | -0.8411 | -0.4613 | -1.031 | - |
| FCF margin | 1,604.21% | 129.21% | -157.21% | -235.92% | -2,061.19% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/16/18 | 8/1/19 | 7/28/20 | 7/23/21 | 7/31/22 | 1/15/24 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 0.01 | - | - | - | - |
| Net Cash position 1 | 0.32 | - | 0.47 | 1.67 | 0.46 | 0.2 |
| Leverage (Debt/EBITDA) | - | -0.0139 x | - | - | - | - |
| Free Cash Flow 1 | 0.24 | 0.79 | -0.84 | -0.46 | -1.03 | - |
| ROE (net income / shareholders' equity) | -86.1% | -40% | -17.7% | -24% | -21.3% | - |
| ROA (Net income/ Total Assets) | -21% | -10.8% | -11.7% | -15.4% | -14.5% | - |
| Assets 1 | 8.751 | 15.39 | 6.462 | 8.136 | 7.673 | - |
| Book Value Per Share 2 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0.0100 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capex 1 | 0.04 | 0 | 0.01 | 0 | - | - |
| Capex / Sales | 293.96% | 0.21% | 2.01% | 0.31% | - | - |
| Announcement Date | 8/16/18 | 8/1/19 | 7/28/20 | 7/23/21 | 7/31/22 | 1/15/24 |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -41.54% | 1.94M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- LVRT Stock
- Financials Nuformix plc
